A Retrospective Epidemiological Study to Map Out Patients With Chronic Obstructive Pulmonary Disease (COPD) and Describe COPD Health Care in Real-Life Primary Care During the First Ten Years of the 21th Century

AstraZeneca1 site in 1 country27,394 target enrollmentJune 2010

ConditionsChronic Obstructive Pulmonary Disease

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Chronic Obstructive Pulmonary Disease
Sponsor: AstraZeneca
Enrollment: 27394
Locations: 1
Primary Endpoint: Describe the development of COPD health care structure in primary care.
Status: Completed
Last Updated: 11 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The aim of this study is to describe COPD health care and to assess demographics, concurrent diseases and mortality and the use of pharmaceuticals for a chronic obstructive pulmonary disease (COPD) population in real life in primary care during the last ten years.

Registry

clinicaltrials.gov

Start Date

June 2010

End Date

September 2011

Last Updated

11 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

AstraZeneca

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•COPD diagnosis according to medical records.
•Use of drugs prescribed for obstructive lung diseases

Exclusion Criteria

Not provided

Outcomes

Primary Outcomes

Describe the development of COPD health care structure in primary care.

Time Frame: Data will be extracted from the medical records on one occassion, covering a period of one decade.

Secondary Outcomes

Describe the COPD population in primary care with special reference to treatment, co-morbidity and mortality during last decade.(Data will be extracted from the medical records on one occassion, covering a period of one decade.)